Other diabetes treatments included liraglutide (26%), dipeptidyl peptidase-4 inhibitors (15%), sulfonylurea (18%), sodium-glucose transport inhibitor (SGLT2i) (9%), and insulin (39%). The gene discussed is INS; the disease is diabetes mellitus.